DBG
De Burlo Group Portfolio holdings
AUM
$759M
1-Year Return
24.77%
This Quarter Return
-9.63%
1 Year Return
+24.77%
3 Year Return
+146.35%
5 Year Return
+326.03%
10 Year Return
+1,922.48%
AUM
$357M
AUM Growth
-$138M
(-28%)
Cap. Flow
-$91.9M
Cap. Flow
% of AUM
-25.76%
Top 10 Holdings %
Top 10 Hldgs %
47.67%
Holding
86
New
5
Increased
13
Reduced
45
Closed
18
Top Buys
| 1 |
Veeva Systems
VEEV
|
$10.6M |
| 2 |
Salesforce
CRM
|
$9.02M |
| 3 |
Amazon
AMZN
|
$8.78M |
| 4 |
AbbVie
ABBV
|
$7.69M |
| 5 |
Allstate
ALL
|
$7.43M |
Top Sells
| 1 |
PNC Financial Services
PNC
|
$15.9M |
| 2 |
Stanley Black & Decker
SWK
|
$12.3M |
| 3 |
Merck
MRK
|
$12.1M |
| 4 |
Essent Group
ESNT
|
$11.8M |
| 5 |
Edwards Lifesciences
EW
|
$10.6M |
Sector Composition
| 1 | Technology | 33.62% |
| 2 | Healthcare | 24.24% |
| 3 | Financials | 14.33% |
| 4 | Communication Services | 7.36% |
| 5 | Consumer Discretionary | 6.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
26
Edwards Lifesciences
EW
$47.5B
| $5.83M | 1.63% |
92,700
-169,200
| -65% | -$10.6M |
|
27
Agilent Technologies
A
$36.4B
| $4.35M | 1.22% |
+60,700
| New | +$4.35M |
|
28
American Tower
AMT
$91.4B
| $4.22M | 1.18% |
19,370
-50
| -0.3% | -$10.9K |
|
29
Danaher
DHR
$143B
| $3.87M | 1.09% |
31,573
-225
| -0.7% | -$27.6K |
|
30
Verizon
VZ
$186B
| $3.73M | 1.04% |
69,365
-4,400
| -6% | -$236K |
|
31
Thermo Fisher Scientific
TMO
$185B
| $3.64M | 1.02% |
12,839
+100
| +0.8% | +$28.4K |
|
32
lululemon athletica
LULU
$24.7B
| $3.37M | 0.95% |
17,800
-36,050
| -67% | -$6.83M |
|
|
VAR
33
DELISTED
Varian Medical Systems, Inc.
VAR
| $3.03M | 0.85% |
+29,515
| New | +$3.03M |
|
34
Masimo
MASI
$7.77B
| $2.6M | 0.73% |
14,650
-550
| -4% | -$97.4K |
|
35
Illumina
ILMN
$15.5B
| $2.53M | 0.71% |
9,512
-565
| -6% | -$150K |
|
36
Stryker
SYK
$151B
| $2.15M | 0.6% |
12,900
-500
| -4% | -$83.3K |
|
37
UnitedHealth
UNH
$281B
| $1.93M | 0.54% |
7,750
-650
| -8% | -$162K |
|
38
Church & Dwight Co
CHD
$23.2B
| $1.87M | 0.53% |
29,200
-200
| -0.7% | -$12.8K |
|
39
General Mills
GIS
$26.5B
| $1.58M | 0.44% |
29,850
-900
| -3% | -$47.5K |
|
40
Procter & Gamble
PG
$373B
| $1.31M | 0.37% |
11,928
-82,950
| -87% | -$9.12M |
|
41
American Water Works
AWK
$27.6B
| $1.06M | 0.3% |
8,850
-37,000
| -81% | -$4.42M |
|
42
Neurocrine Biosciences
NBIX
$13.9B
| $1.02M | 0.29% |
11,750
-300
| -2% | -$26K |
|
43
Masco
MAS
$15.5B
| $875K | 0.25% |
25,300
-1,100
| -4% | -$38K |
|
44
Atmos Energy
ATO
$26.5B
| $854K | 0.24% |
8,610
-7,790
| -48% | -$773K |
|
45
Bright Horizons
BFAM
$6.62B
| $846K | 0.24% |
8,300
-600
| -7% | -$61.2K |
|
46
Washington Trust Bancorp
WASH
$583M
| $806K | 0.23% |
22,041
+14,777
| +203% | +$540K |
|
47
Henry Schein
HSIC
$8.22B
| $790K | 0.22% |
15,630
-9,280
| -37% | -$469K |
|
48
Steris
STE
$24B
| $763K | 0.21% |
5,450
-100
| -2% | -$14K |
|
49
Gilead Sciences
GILD
$140B
| $689K | 0.19% |
9,215
-5,075
| -36% | -$379K |
|
50
Integra LifeSciences
IART
$1.22B
| $643K | 0.18% |
14,398
-100
| -0.7% | -$4.47K |
|